Briplatin and myelodysplastic syndrome Patient Reports February 12, 2012

Briplatin Side Effects Report #5406330-9
Briplatin side effect was reported by a Health Professional from JAPAN on Aug 02, 2007. Female patient, 69 years of age, was diagnosed with uterine cancer  and was treated with Briplatin. After drug was administered, patient experienced the following side effects: immunodeficiency, myelodysplastic syndrome, sepsis . Briplatin dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS. Patient was hospitalized. Patient died on 07/19/2006.

Briplatin Side Effects Report #5367794-2
Briplatin side effect was reported by a Health Professional from JAPAN on June 20, 2007. Female patient, 64 years of age, was diagnosed with uterine cancer  and was treated with Briplatin. After drug was administered, patient experienced the following side effects: immunodeficiency, myelodysplastic syndrome, sepsis . Briplatin dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS. Patient died.

Briplatin Side Effects Report #5444322-4
Briplatin side effect was reported by a Health Professional from JAPAN on Sept 04, 2007. Female patient, 64 years of age, was diagnosed with uterine cancer  and was treated with Briplatin. After drug was administered, patient experienced the following side effects: immunodeficiency, myelodysplastic syndrome, sepsis . Briplatin dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS. Patient was hospitalized. Patient died on 07/19/2006.

Briplatin Side Effects Report #5525285-X
Briplatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2007. Male patient, 67 years of age, weighting 101.4 lb, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, lymphocyte count decreased, myelodysplastic syndrome, neutrophil count decreased, platelet count decreased, renal impairment, white blood cell count decreased. Briplatin dosage: unknown. During the same period patient was treated with ALIMTA, GEMZAR, PANVITAN, CYANOCOBALAMIN. Patient was hospitalized and became disabled. Patient recovered.


Briplatin Side Effects Report #5599882-X
Briplatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2008. Male patient, 67 years of age, weighting 101.4 lb, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, lymphocyte count decreased, malignant neoplasm progression, myelodysplastic syndrome, neutrophil count decreased, platelet count decreased, reflux oesophagitis, renal impairment, white blood cell count decreased. Briplatin dosage: unknown. During the same period patient was treated with PARAPLATIN, ALIMTA, GEMZAR, PANVITAN, CYANOCOBALAMIN, TAKEPRON, KYTRIL, DECADRON. Patient was hospitalized and became disabled. Patient died on 12/07/2007.

Briplatin Side Effects Report #5406128-1
Briplatin side effect was reported by a Health Professional from JAPAN on Aug 02, 2007. Female patient, 58 years of age, was diagnosed with ovarian cancer and was treated with Briplatin. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Briplatin dosage: unknown. During the same period patient was treated with VEPESID, ENDOXAN, ADRIAMYCIN PFS, IRINOTECAN. Patient died on 04/02/2004.

Briplatin Side Effects Report #5367789-9
Briplatin side effect was reported by a Health Professional from JAPAN on June 20, 2007. Female patient, 49 years of age, was diagnosed with ovarian cancer and was treated with Briplatin. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Briplatin dosage: unknown. During the same period patient was treated with VEPESID, ADRIAMYCIN PFS, ENDOXAN, IRINOTECAN. Patient died.

Briplatin Side Effects Report #5444861-6
Briplatin side effect was reported by a Health Professional from JAPAN on Sept 03, 2007. Female patient, 49 years of age, was diagnosed with ovarian cancer and was treated with Briplatin. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Briplatin dosage: unknown. During the same period patient was treated with VEPESID, ENDOXAN, ADRIAMYCIN PFS, IRINOTECAN. Patient died on 04/02/2004.